Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Cross Over, Placebo Controlled, Multiple-dose Study to Evaluate the Effects of LAF237 on Gastric Emptying, Gastric Volume and Satiety in Patients With Type 2 Diabetes.

NCT00952991 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00952991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00952991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Cross Over, Placebo Controlled, Multiple-dose Study to Evaluate the Effects of LAF237 on Gastric Emptying, Gastric Volume and Satiety in Patients With Type 2 Diabetes.
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2005
Completion date
February 28, 2006
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, non-insulin-dependent